126 related articles for article (PubMed ID: 32037090)
1. Inhibition of arachidonate lipoxygenase12 targets lung cancer through inhibiting EMT and suppressing RhoA and NF-κB activity.
Chen J; Tong W; Liao M; Chen D
Biochem Biophys Res Commun; 2020 Apr; 524(4):803-809. PubMed ID: 32037090
[TBL] [Abstract][Full Text] [Related]
2. ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.
Huang Z; Xia L; Zhou X; Wei C; Mo Q
Biochem Biophys Res Commun; 2019 Jun; 514(1):24-30. PubMed ID: 31014671
[TBL] [Abstract][Full Text] [Related]
3. Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis.
Yang F; Zhang Y; Ren H; Wang J; Shang L; Liu Y; Zhu W; Shi X
J Exp Clin Cancer Res; 2019 Dec; 38(1):489. PubMed ID: 31831037
[TBL] [Abstract][Full Text] [Related]
4. Knockout of ALOX12 protects against spinal cord injury-mediated nerve injury by inhibition of inflammation and apoptosis.
Li JL; Liang YL; Wang YJ
Biochem Biophys Res Commun; 2019 Aug; 516(3):991-998. PubMed ID: 31277941
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
6. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells.
Kandouz M; Nie D; Pidgeon GP; Krishnamoorthy S; Maddipati KR; Honn KV
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):189-204. PubMed ID: 14518561
[TBL] [Abstract][Full Text] [Related]
7. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer.
Huang J; Cao D; Sha J; Zhu X; Han S
Biochem Biophys Res Commun; 2019 Jun; 514(3):853-860. PubMed ID: 31079917
[TBL] [Abstract][Full Text] [Related]
8. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
9. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
11. Aberrant ALOX5 Activation Correlates with HER2 Status and Mediates Breast Cancer Biological Activities through Multiple Mechanisms.
Zhou X; Jiang Y; Li Q; Huang Z; Yang H; Wei C
Biomed Res Int; 2020; 2020():1703531. PubMed ID: 33224971
[TBL] [Abstract][Full Text] [Related]
12. TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.
Hu Y; He K; Wang D; Yuan X; Liu Y; Ji H; Song J
Carcinogenesis; 2013 Aug; 34(8):1764-72. PubMed ID: 23615405
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
15. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
16. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.
Hauser AD; Bergom C; Schuld NJ; Chen X; Lorimer EL; Huang J; Mackinnon AC; Williams CL
Mol Cancer Res; 2014 Jan; 12(1):130-42. PubMed ID: 24197117
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CCR7 promotes NF-κB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
Zhang L; Xiao X; An H; Wang J; Ma Y; Qian YH
Oncol Rep; 2017 May; 37(5):2913-2919. PubMed ID: 28339080
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6-triggered ataxia-telangiectasia mutated kinase activation facilitates epithelial-to-mesenchymal transition in lung cancer by upregulating vimentin expression.
Jiang YN; Ni XY; Yan HQ; Shi L; Lu NN; Wang YN; Li Q; Gao FG
Exp Cell Res; 2019 Aug; 381(2):165-171. PubMed ID: 31100307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]